The Impact of Adjuvant Postoperative Radiation Therapy and Chemotherapy on Survival After Esophagectomy for Esophageal Carcinoma

被引:49
|
作者
Wong, Andrew T. [1 ,2 ]
Shao, Meng [1 ,2 ]
Rineer, Justin [3 ]
Lee, Anna [1 ,2 ]
Schwartz, David [1 ,2 ]
Schreiber, David [1 ,2 ]
机构
[1] Dept Vet Affairs New York Harbor Healthcare Syst, Dept Radiat Oncol, Brooklyn, NY USA
[2] Suny Downstate Med Ctr, Dept Radiat Oncol, 450 Clarkson Ave,Box 1211, Brooklyn, NY 11203 USA
[3] UF Hlth Canc Ctr Orlando Hlth, Dept Radiat Oncol, Orlando, FL USA
关键词
chemotherapy; esophageal cancer; esophagectomy; radiation therapy; SQUAMOUS-CELL CARCINOMA; THORACIC ESOPHAGUS; RANDOMIZED TRIAL; RADIOTHERAPY; SURGERY; CANCER; CHEMORADIOTHERAPY; RESECTION;
D O I
10.1097/SLA.0000000000001825
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: The objective of this study was to analyze the impact on overall survival (OS) from the addition of postoperative radiation with or without chemotherapy after esophagectomy, using a large, hospital-based dataset. Background: Previous retrospective studies have suggested an OS advantage for postoperative chemoradiation over surgery alone, although prospective data are lacking. Methods: The National Cancer Data Base was queried to select patients diagnosed with stage pT3-4Nx-0M0 or pT1-4N1-3M0 esophageal carcinoma (squamous cell or adenocarcinoma) from 1998 to 2011 treated with definitive esophagectomy +/- postoperative radiation and/or chemotherapy. OS was analyzed using the Kaplan-Meier method and compared using the log-rank test. Multivariate Cox regression analysis was used to identify covariates associated with OS. Results: There were 4893 patients selected, of whom 1153 (23.6%) received postoperative radiation. Most patients receiving radiation also received sequential/concomitant chemotherapy (89.9%). For the entire cohort, postoperative radiation was associated with a statistically significant but modest absolute improvement in survival (hazard ratio 0.77; 95% CI, 0.71-0.83; P < 0.001). On subgroup analysis, postoperative radiation was associated with improved OS for patients with node-positive disease (3-yr OS 34.3 % vs 27.8%, P < 0.001) or positive margins (3-yr OS 36.4% vs 18.0%, P < 0.001). When chemotherapy usage was incorporated, sequential chemotherapy was associated with the best survival (P < 0.001). Multivariate analysis revealed that the addition of chemotherapy to radiation therapy, whether sequentially or concurrently, was a strong prognostic factor for OS. Conclusions: In this hospital-based study, the addition of postoperative chemoradiation (either sequentially or concomitantly) after esophagectomy was associated with improved OS for patients with node-positive disease or positive margins.
引用
下载
收藏
页码:1146 / 1151
页数:6
相关论文
共 50 条
  • [1] Impact of Postoperative Radiation after Esophagectomy for Esophageal Cancer
    Schreiber, David
    Rineer, Justin
    Vongtama, Dan
    Wortham, Angela
    Han, Peter
    Schwartz, David
    Choi, Kwang
    Rotman, Marvin
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (02) : 244 - 250
  • [2] The Impact of Adjuvant Therapy on Survival After Esophagectomy for Node-negative Esophageal Adenocarcinoma
    Rucker, A. Justin
    Raman, Vignesh
    Jawitz, Oliver K.
    Voigt, Soraya L.
    Harpole, David H.
    D'Amico, Thomas A.
    Tong, Betty C.
    ANNALS OF SURGERY, 2022, 275 (02) : 348 - 355
  • [3] Comment on: The Impact of Adjuvant Therapy on Survival After Esophagectomy for Node-Negative Esophageal Adenocarcinoma
    Wang, Sichao
    Huang, Shujie
    Gao, Zhen
    Zhuang, Weitao
    Chen, Rixin
    Qiao, Guibin
    ANNALS OF SURGERY, 2022, 276 (05) : E645 - E645
  • [4] Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma
    Bates, BA
    Detterbeck, FC
    Bernard, SA
    Qaqish, BF
    Tepper, JE
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (01) : 156 - 163
  • [5] CHEMOTHERAPY AND RADIATION-THERAPY BEFORE TRANSHIATAL ESOPHAGECTOMY FOR ESOPHAGEAL-CARCINOMA
    ORRINGER, MB
    FORASTIERE, AA
    PEREZTAMAYO, C
    URBA, S
    TAKASUGI, BJ
    BROMBERG, J
    ANNALS OF THORACIC SURGERY, 1990, 49 (03): : 348 - 355
  • [6] Survival After Induction Chemotherapy and Esophagectomy Is Not Improved by Adjuvant Chemotherapy
    Yan, Wanpu
    Zhao, Peiliang
    Fu, Hao
    Lin, Yao
    Li, Zhongwu
    Dai, Liang
    Yang, Yongbo
    Kang, Xiaozheng
    Chen, Ke-Neng
    ANNALS OF THORACIC SURGERY, 2019, 108 (05): : 1505 - 1513
  • [7] Impact of Tumor Size on Survival Outcome in Esophageal Squamous Cell Carcinoma After Esophagectomy Following Neoadjuvant Chemotherapy
    Koterazawa, Yasufumi
    Oshikiri, Taro
    Goto, Hironobu
    Kato, Takashi
    Sawada, Ryuichiro
    Harada, Hitoshi
    Urakawa, Naoki
    Hasegawa, Hiroshi
    Kanaji, Shingo
    Yamashita, Kimihiro
    Matsuda, Takeru
    Kakeji, Yoshihiro
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (04) : 2482 - 2489
  • [8] Impact of Tumor Size on Survival Outcome in Esophageal Squamous Cell Carcinoma After Esophagectomy Following Neoadjuvant Chemotherapy
    Yasufumi Koterazawa
    Taro Oshikiri
    Hironobu Goto
    Takashi Kato
    Ryuichiro Sawada
    Hitoshi Harada
    Naoki Urakawa
    Hiroshi Hasegawa
    Shingo Kanaji
    Kimihiro Yamashita
    Takeru Matsuda
    Yoshihiro Kakeji
    Annals of Surgical Oncology, 2024, 31 : 2482 - 2489
  • [9] Does Adjuvant Chemotherapy Provide Additional Survival Benefit After Neoadjuvant Chemotherapy or Chemoradiotherapy and Esophagectomy for Esophageal Adenocarcinoma?
    Kamarajah, Sivesh
    Markar, Sheraz
    Phillips, Alexander
    Kunene, Victoria
    Fackrell, David
    Salti, George
    Dahdaleh, Fadi
    Griffiths, Ewen
    BRITISH JOURNAL OF SURGERY, 2021, 108
  • [10] Adjuvant chemotherapy in node-positive patients after esophagectomy for esophageal squamous cell carcinoma
    Jeon, Yeong Jeong
    Cho, Jong Ho
    Choi, Yong Soo
    Shim, Young Mog
    Sun, Jong-Mu
    Kim, Hong Kwan
    THORACIC CANCER, 2023, 14 (06) : 624 - 635